Please login to the form below

Not currently logged in
Email:
Password:

Dihon

This page shows the latest Dihon news and features for those working in and with pharma, biotech and healthcare.

Bayer puts research at heart of business growth

Bayer puts research at heart of business growth

This area has been boosted over the past year with the acquisition of Merck &Co's consumer health division and the takeover of China-based Dihon Pharmaceutical.

Latest news

  • Bayer completes takeover of Chinese OTC company Bayer completes takeover of Chinese OTC company

    Bayer completes takeover of Chinese OTC company. Expands consumer health presence with Dihon purchase. ... Germany's Bayer has completed its acquisition of the China-based consumer healthcare company Dihon Pharmaceutical.

  • Pharma is turning its attention to consumer healthcare Pharma is turning its attention to consumer healthcare

    The company also bought Chinese based Dihon Pharmaceuticals, which specialises in OTC medicines and traditional herbal remedies, to increase its offering and presence in Asia. “

  • Bayer raises sales predictions for new pharma products Bayer raises sales predictions for new pharma products

    Fresh from announcing a deal to buy Chinese over-the-counter drugmaker Dihon Pharmaceutical, Bayer also reported a 4 per cent sales decline for its consumer health division to 1.96bn - ... Consumer health should return to low- to mid-single-digit growth

  • Bayer buys Chinese consumer care company Bayer buys Chinese consumer care company

    Bayer buys Chinese consumer care company. Acquires Dihon Pharmaceutical as Algeta takeover closes. ... Bayer has boosted its consumer healthcare operations in emerging markets with a deal to acquire China-based Dihon Pharmaceutical Group.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Sustainable solutions Sustainable solutions

    This was followed five months later by the smaller, but still notable, deal to acquire the Chinese consumer healthcare company Dihon Pharmaceutical for around $485m.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics